Status
Conditions
Treatments
About
Rotational atherectomy (RA) facilitates percutaneous coronary intervention for complex de novo lesions with severe calcification. Some observational studies and a small randomized trial indicated that a strategy of routine RA did not conferred reduction in restenosis or MACE, but these studies are limited by missing follow-up, insufficient power to compare outcomes, and confounding factors in the RA group (long lesion length, etc.). With recent developments in medical therapy, advances in design and delivery of drug-eluting stents (DES), and advances in noninvasive and intravascular coronary imaging, the use of RA in current real-world practice remains to be well determined. We aimed to compile real-world clinical outcomes data for the RotablatorTM Rotational Atherectomy System in routine clinical practice in China.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age ≥18 years old
Subject who is clinically indicated for PCI/stenting
Written informed consent
Subject is willing to comply with all protocol-required follow-up evaluation
Subject must meet one of following angiographic/procedural inclusion criteria:
Exclusion criteria
Subject has clinical symptoms and/or electrocardiogram (ECG) changes consistent with acute MI within 2 weeks
Subject has any of the following angiographic findings:
980 participants in 1 patient group
Loading...
Central trial contact
Xiao Wang, MD; Shao-Ping Nie, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal